For real-time updates on NKTR, beat the news and login or try Benzinga Pro.
Nektar Therapeutics NKTR today had a large opening gap of -64.28%.
Photo taken from the Opening Gap Signals tool inside Benzinga Pro.
Why Is NKTR Moving?
Nektar Therapeutics shares are trading lower after the company reported worse-than-expected Q2 sales results. JPMorgan also downgraded the company’s stock from Overweight to Neutral. The company also said it has experienced delays with its bempegaldesleukin program.
Photo taken from the ‘Why Is It Moving?’ Details tool inside Benzinga Pro.
For live updates on NKTR, log in or try Benzinga Pro today.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.